Dow Up0.08% Nasdaq Down0.30%

Novartis AG (NVS)

-NYSE
93.90 Down 0.90(0.95%) 4:04PM EDT
|After Hours : 93.90 0.00 (0.00%) 4:43PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 58,831,000   57,561,000   59,375,000  
Cost of Revenue19,608,000  18,756,000  18,983,000  
Gross Profit 39,223,000   38,805,000   40,392,000  
Operating Expenses
Research Development9,852,000  9,332,000  9,583,000  
Selling General and Administrative18,461,000  18,280,000  20,029,000  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 10,910,000   11,193,000   10,780,000  
Income from Continuing Operations
Total Other Income/Expenses Net(92,000)(96,000)(2,000)
Earnings Before Interest And Taxes11,418,000  11,649,000  11,306,000  
Interest Expense683,000  724,000  751,000  
Income Before Tax10,735,000  10,925,000  10,555,000  
Income Tax Expense1,443,000  1,542,000  1,483,000  
Minority Interest -   -   -  
Net Income From Continuing Ops9,892,000  9,935,000  9,600,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 9,292,000   9,383,000   9,072,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 9,292,000   9,383,000   9,072,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.